Understanding antibiotic resistance in gonorrhea among men on PrEP in Vietnam
Antimicrobial resistance in Neisseria gonorrhoeae among men on PrEP in Vietnam
This study is looking at how common antibiotic resistance is in gonorrhea among men who have sex with men in Vietnam who are using a prevention program, and it aims to find out what might make treatment less effective so that better care can be provided.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10892806 on NIH RePORTER |
What this research studies
This research investigates the growing problem of antibiotic resistance in Neisseria gonorrhoeae, particularly among men who have sex with men (MSM) participating in a pre-exposure prophylaxis (PrEP) program in Vietnam. The study will assess how common antibiotic resistance is in this population and identify risk factors associated with treatment failures. By utilizing whole-genome sequencing, researchers aim to gain insights into the genetic makeup of resistant strains, which will help inform better treatment strategies. Regular testing for gonorrhea will be integrated into the existing PrEP program to monitor and address these issues effectively.
Who could benefit from this research
Good fit: Ideal candidates for participation are men who have sex with men and are enrolled in a PrEP program in Vietnam.
Not a fit: Patients who are not men who have sex with men or those not participating in a PrEP program may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for gonorrhea, reducing the risk of untreatable infections.
How similar studies have performed: Previous research has shown that addressing antimicrobial resistance through targeted studies can lead to significant improvements in treatment outcomes, suggesting this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Adamson, Paul C — University of California Los Angeles
- Study coordinator: Adamson, Paul C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.